## Core Concept
The Transjugular Intrahepatic Portosystemic Shunt (TIPSS) is a medical intervention used primarily to treat complications of portal hypertension, such as refractory ascites and variceal bleeding. The procedure involves creating a shunt between the hepatic vein and the portal vein to reduce portal pressure. However, like any medical intervention, it comes with potential complications.

## Why the Correct Answer is Right
The most common complication following TIPSS is **hepatic encephalopathy**. This occurs because the shunt created between the portal and hepatic veins allows blood to bypass the liver, potentially leading to an increase in ammonia and other toxins in the systemic circulation. These toxins can cross the blood-brain barrier and cause encephalopathy. The risk of developing hepatic encephalopathy post-TIPSS is significant because it directly relates to the diversion of blood flow away from the liver's detoxifying capabilities.

## Why Each Wrong Option is Incorrect
- **Option A:** While **infection** can be a complication of many medical procedures, including TIPSS, it is not the most common complication specifically associated with this intervention.
- **Option B:** **Shunt stenosis or occlusion** is indeed a complication of TIPSS, but it is not as immediately prevalent or as frequently encountered as hepatic encephalopathy in the early post-procedure period.
- **Option C:** (Assuming this is an incorrect option not directly provided)
- **Option D:** (Assuming this is an incorrect option not directly provided)

## Clinical Pearl / High-Yield Fact
A key clinical pearl for TIPSS is that **patients with a history of hepatic encephalopathy are at higher risk of developing it again post-procedure**. Therefore, careful patient selection and monitoring are crucial. Additionally, the use of certain medications like lactulose or rifaximin may help mitigate this risk.

## Correct Answer: B. Hepatic encephalopathy.